Drugs

eISSN: 1179-1950pISSN: 0012-6667

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
16.3
H-Index
179
Impact Factor
10 - 15
SJR
Q1Pharmacology (medical)
SNIP
2.68

Journal Specifications

Overview
  • Publisher
    ADIS INT LTD
  • Language
    English
  • Frequency
    Semi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Lung cancer
Multiple sclerosis
Body mass index
Breast cancer
Hemodialysis
Antipruritic Activity
Psoriatic arthritis
Spinal muscular atrophy
Type 2 diabetes
Lonafarnib
Gefitinib
Psoriasis
Immunotherapy
Migraine
Filgotinib
Clinical trial
Dexamethasone
Overall survival
Capsaicin
Fabry disease

Recently Published Papers

Year-wise Publication

FAQs

Since when has Drugs been publishing? Faqs

The Drugs has been publishing since 1971 till date.

How frequently is the Drugs published? Faqs

Drugs is published Semi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Drugs? Faqs

Drugs has a H-index score of 179, Citescore of 16.3, SNIP score of 2.68, & SJR of Q1

Who is the publisher of Drugs? Faqs

The publisher of Drugs is ADIS INT LTD.

How can I view the journal metrics of Drugs on editage? Faqs

For the Drugs metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Drugs? Faqs

The eISSN number is 1179-1950 and pISSN number is 0012-6667 for Drugs.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Lung cancer, Multiple sclerosis, Body mass index, Breast cancer, Hemodialysis, Antipruritic Activity, Psoriatic arthritis, Spinal muscular atrophy, Type 2 diabetes, Lonafarnib, Gefitinib, Psoriasis, Immunotherapy, Migraine, Filgotinib, Clinical trial, Dexamethasone, Overall survival, Capsaicin, Fabry disease.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.